India's Sun Pharma to buy US-listed Organon in about $11.8 billion deal Reuters
Sun Pharmaceutical Industries will acquire Organon & Co in an all-cash deal, valuing the US drugmaker at about $11.75 billion including debt, in one of India's biggest outbound deals. The acquisition